Keymed Biosciences Inc. (HKG:2162)

Keymed Biosciences Revenue

Keymed Biosciences had revenue of 617.07M CNY in the half year ending June 30, 2026, with 1,028.47% growth. This brings the company's total for the last twelve months to 834.63M, down -4.31% year-over-year. In the year 2025, Keymed Biosciences had annual revenue of 716.31M with 67.31% growth. That makes Keymed Biosciences the 21,089th largest company in the world by revenue and 1,234th in Hong Kong.

• Revenue (ttm): 834.63M CNY
• Revenue Growth: -4.31%
• P/S Ratio: 26.48
• Revenue / Employee: 472.08K CNY
• Employees: 1,768
• Market Cap: 25.41B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• United States of America 393.67M 55.0%
• Mainland China 322.17M 45.0%
• United Kingdom 474.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Keymed Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	716.31M	288.19M	67.31%
Dec 31, 2024	428.12M	74.03M	20.91%
Dec 31, 2023	354.10M	254.03M	253.87%
Dec 31, 2022	100.06M	-10.21M	-9.26%
Dec 31, 2021	110.27M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error